Korea South
WELT corp is a Wellness Technology startup that develops personalized digital therapeutics and wearables. Spun off from Samsung Electronics in 2016, the company has experienced explosive growth, expanding into the United States and Japan and attracting over KRW14.00B in cumulative investments.
As a part of its core business, WELT is actively pursuing the development of Digital Therapeutics (DTx) and Digital Biomarkers. It aims to develop three or more DTx for mental health conditions over the next three years, with plans to obtain regulatory approval from the Korean Food and Drug Administration.
The company's last investment of KRW14.00B in a Series C round took place on 26 June 2024 and was led by Envisioning Partners, Handok, IMM Investment, Industrial Bank of Korea, and Shinhan Venture Investment.
With its exceptional team, WELT seeks to attract individuals who are passionate about revolutionizing healthcare.
-logo.jpg "Roubit (루빗)"){kind=logo}
